[
    [
        {
            "time": "2019-08-27",
            "original_text": "科創板上市委：華熙生物、博瑞醫藥首發事項定於8月27日上會",
            "features": {
                "keywords": [
                    "科創板",
                    "華熙生物",
                    "博瑞醫藥",
                    "首發",
                    "上會"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "醫療健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "科創板上市委：華熙生物、博瑞醫藥首發事項定於8月27日上會",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-08-27",
            "original_text": "科創板上市委：定於8月27日審議華熙生物、博瑞生物首發申請",
            "features": {
                "keywords": [
                    "科創板",
                    "華熙生物",
                    "博瑞生物",
                    "首發",
                    "審議"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "醫療健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "科創板上市委：定於8月27日審議華熙生物、博瑞生物首發申請",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-08-27",
            "original_text": "每經小強快訊：華熙生物科技股份有限公司和華泰聯合證券有限責任公司關於審核中心意見落實函的回復",
            "features": {
                "keywords": [
                    "華熙生物",
                    "華泰聯合證券",
                    "審核中心意見",
                    "落實函",
                    "回復"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "每經小強快訊：華熙生物科技股份有限公司和華泰聯合證券有限責任公司關於審核中心意見落實函的回復",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-08-27",
            "original_text": "科創板擬上市企業博瑞醫藥、華熙生物披露上會稿",
            "features": {
                "keywords": [
                    "科創板",
                    "博瑞醫藥",
                    "華熙生物",
                    "上會稿",
                    "披露"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "醫療健康"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "科創板擬上市企業博瑞醫藥、華熙生物披露上會稿",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]